Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Marine Parasites as Bioindicators for Toxins and Their Potential Role as Environmental Sinks for Marine Fauna.

Journal of parasitology research·2026
Same author

Diagnosis and Management of Intrauterine Pathology.

Gynecology and minimally invasive therapy·2026
Same author

Choroidal coloboma masquerading as regressed retinoblastoma.

BMJ case reports·2026
Same author

In-office bleaching effect with different concentrations of hydrogen peroxide on enamel color and demineralization.

Bioinformation·2026
Same author

Effect Sizes and Statistical Power in Hearing Aid Research.

American journal of audiology·2026
Same author

Perinatal Neuroprotective Strategies and Intraventricular Hemorrhage in Preterm Infants ≤32 Weeks' Gestational Age: A Prospective Study With a Historical Control Cohort.

Cureus·2026

Related Experiment Video

Updated: May 20, 2025

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:23

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

178

Nanomanaging Chronic Wounds with Targeted Exosome Therapeutics.

Anita Yadav1, Anu Sharma1, Mohini Moulick1

  • 1McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA.

Pharmaceutics
|March 27, 2025
PubMed
Summary

Exosome-based therapies offer a promising cell-free approach for chronic wound healing. Hydrogel scaffolds enhance exosome delivery for sustained efficacy in challenging wound environments.

Keywords:
biocompatible scaffoldscell–cell communicationengineered exosomesexosome-targeted therapiesfunctional wound closure

More Related Videos

Mouse Wound Models and Preparation of Single-Cell Suspensions
04:03

Mouse Wound Models and Preparation of Single-Cell Suspensions

Published on: September 27, 2024

408
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

24.8K

Related Experiment Videos

Last Updated: May 20, 2025

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:23

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

178
Mouse Wound Models and Preparation of Single-Cell Suspensions
04:03

Mouse Wound Models and Preparation of Single-Cell Suspensions

Published on: September 27, 2024

408
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

24.8K

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Wound Healing Research

Background:

  • Chronic wounds present a significant global health burden, often complicated by infections and a hostile microenvironment.
  • Traditional treatments struggle with poor drug delivery, limited efficacy, and side effects due to inadequate blood supply and biofilm resistance.
  • The need for advanced therapeutic strategies is critical to overcome the challenges of chronic wound management.

Purpose of the Study:

  • To review the potential of exosome-based therapies for chronic wound treatment.
  • To explore the advantages of exosomes, such as biocompatibility and targeted delivery, in wound healing.
  • To discuss strategies for overcoming exosome clearance and enhancing therapeutic efficacy in chronic wounds.

Main Methods:

  • Literature review focusing on exosome biology and therapeutic applications in wound healing.
  • Analysis of exosome properties, including biocompatibility, immunogenicity, and cell-to-cell communication.
  • Evaluation of drug delivery systems, such as hydrogels and scaffolds, for sustained exosome release.

Main Results:

  • Exosomes offer a cell-free therapeutic advantage with inherent biocompatibility and low immunogenicity.
  • Engineered exosomes demonstrate enhanced stability and efficacy in promoting wound healing compared to native exosomes.
  • Hydrogel and scaffold-based delivery systems show promise for prolonging exosome presence and therapeutic effect at wound sites.

Conclusions:

  • Exosome-based therapies represent a novel and effective strategy for chronic wound management.
  • Biocompatible scaffolds and hydrogels are crucial for optimizing exosome delivery and sustained therapeutic action.
  • Further research is essential to translate the clinical potential of exosome therapies into effective treatments for chronic wounds.